Hydrocortisone with oxytetracycline
Brand names: Terra-Cortril
This combination preparation contains the mild corticosteroid hydrocortisone with the tetracycline antibiotic oxytetracycline, used topically for inflammatory skin conditions with secondary bacterial infection.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Hydrocortisone reduces local inflammation via glucocorticoid receptors, while oxytetracycline inhibits bacterial protein synthesis by binding the 30S ribosomal subunit.
Prescribing in practice
- Limit to short-term use for infected inflammatory dermatoses to avoid steroid atrophy and reduce antibiotic resistance; it is not appropriate for inflammation without infection.
- Be aware the preparation may stain skin or clothing.
- Avoid prolonged or repeated application on the face and flexures.
Monitoring
Review the treated area for resolution of infection and inflammation and step down once it has settled.
Counselling the patient
- Apply thinly to the affected area for the short course only.
- The preparation may stain fabrics, so take care with clothing and bedding.
- Return if the condition spreads or fails to improve.
Evidence & guidelines
Topical steroid-antibiotic combinations are reserved for inflammatory skin disease with secondary infection in line with standard prescribing references.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Steroid Dose Equivalence · Medications
- Adrenal Insufficiency Assessment · Adrenal
- Adrenal Crisis Risk Score · Adrenal Disorders
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Steroid Conversion Calculator · Drug Dosing
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD